顶流基金经理最新持仓曝光，年回报率最高近65%

Core Viewpoint - The article highlights the significant divergence in performance among various sectors in the Chinese stock market during Q4 2025, with technology and growth sectors like AI computing and semiconductors outperforming traditional sectors such as real estate and pharmaceuticals [1][2][4]. Summary by Sections Market Performance - In Q4 2025, the Shanghai Composite Index rose by 2.22%, while the CSI 300 Index fell by 0.23%, and the ChiNext Index decreased by 1.08%. The Hang Seng Index dropped by 4.56%, and the Hang Seng China Enterprises Index fell by 6.72% [1]. Fund Manager Strategies - Star fund managers like Fu Pengbo and Li Xiaoxing achieved significant excess returns, with Fu's Ruiyuan Growth Value Fund and Li's Yinhua Small Cap Select both rising over 60% in 2025, driven by heavy investments in AI computing and semiconductors [1][2]. - Balanced allocation funds, such as Zhu Shaoxing's Fuguo Tianhui Select Growth A, showed stable performance with over 20% annual growth, benefiting from diversified holdings across multiple sectors [2][12]. Technology Growth Focus - Funds focusing on technology growth, like those managed by Fu Pengbo and Xie Zhiyu, saw rewards for their strategies, with increased allocations to data center cooling, storage, and computing-related companies [4][5]. - Li Xiaoxing emphasized AI as a key investment theme, with a strong focus on semiconductor companies, indicating a shift towards domestic advanced processes and military-civilian integration opportunities [6]. Traditional Value Sector - Fund managers like Zhang Kun and Liu Yanhun maintained positions in traditional sectors like consumer goods and pharmaceuticals, facing significant net value pressure in Q4 2025. Liu's fund saw a decline of 5.85% in Q4, while Zhang's fund remained stable but adjusted sector allocations [8][10]. - Despite challenges, the pharmaceutical sector showed signs of improvement due to policy changes and innovation, with opportunities emerging in innovative drug chains and medical devices [9][10]. Consensus Among Fund Managers - Despite differing investment styles, fund managers shared common views on the impact of "anti-involution" policies on corporate fundamentals and the relative attractiveness of equity assets in the current market environment [16][17]. - The importance of stock selection has increased significantly, with a focus on identifying core companies with competitive advantages in both growth and value sectors [17].